1. Home
  2. CYTK vs GSAT Comparison

CYTK vs GSAT Comparison

Compare CYTK & GSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

SELL

Current Price

$62.30

Market Cap

10.7B

Sector

Health Care

ML Signal

SELL

Logo Globalstar Inc.

GSAT

Globalstar Inc.

SELL

Current Price

$82.31

Market Cap

10.7B

ML Signal

SELL

Company Overview

Basic Information
Metric
CYTK
GSAT
Founded
1997
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
10.7B
10.7B
IPO Year
2004
2006

Fundamental Metrics

Financial Performance
Metric
CYTK
GSAT
Price
$62.30
$82.31
Analyst Decision
Strong Buy
Buy
Analyst Count
23
3
Target Price
★ $109.40
$90.00
AVG Volume (30 Days)
★ 2.0M
580.7K
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 74.58
EPS
N/A
★ N/A
Revenue
$13,368,000.00
★ $112,660,000.00
Revenue This Year
$72.63
$8.42
Revenue Next Year
$181.06
$20.04
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$54.30
$40.50
52 Week High
$88.31
$84.85

Technical Indicators

Market Signals
Indicator
CYTK
GSAT
Relative Strength Index (RSI) 36.80 46.34
Support Level $59.21 $80.87
Resistance Level $67.65 $83.01
Average True Range (ATR) 2.01 0.67
MACD 0.31 -0.11
Stochastic Oscillator 34.67 29.82

Price Performance

Historical Comparison
CYTK
GSAT

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About GSAT Globalstar Inc.

Globalstar Inc is a telecommunications company that derives revenue from the provision of mobile satellite services. Mobile satellite services, including voice and data communications services to retail, business, and governmental customers, as well as wholesale satellite capacity services. The company provides communications services such as two-way voice and data transmission. In addition, one-way data transmission is also offered. Both services are offered using mobile or fixed devices. The company is the owner of satellite assets. It has one reportable segment: the MSS business. The company generates the vast majority of its revenue within the United States.

Share on Social Networks: